Introduction: Brief concentrated exposure and response prevention (cERP) has shown promise as an efficacious treatment for obsessive-compulsive disorder (OCD) with higher response and remission rates compared to the first-line treatment. However, the mechanisms driving this success remain unclear. Methods: This longitudinal study included 56 patients with OCD who underwent cERP (Bergen 4-day treatment). Treatment mechanisms (e.g., willingness to engage in exposure and response prevention (ERP), confidence in future self-guided ERP, leaning into anxiety) were assessed before and after each of the 4 treatment days by the Pre- and Post-Session Questionnaire (PPSQ-cERP). Changes in the PPSQ-cERP were used to predict treatment response assessed from baseline to post-treatment and 3-month follow-up. Results: All variables assessed by the PPSQ-cERP showed improvement throughout the cERP, as calculated using linear mixed models. Several variables, including willingness to engage in ERP and self-efficacy, improved after day 3, with small to medium effects (0.34–0.70). Confidence in future self-guided ERP improved on day 4 (the day on which it was addressed), with a small effect (0.31). Leaning into anxiety during ERP tasks on day 3 was identified as a predictor of OCD symptom improvement (β = 0.516, p = 0.050) by least absolute shrinkage and selection operator regression, while group cohesion reached trend level (β = 0.239, p = 0.081). Conclusion: This study highlights day-specific effects across all treatment mechanism variables. Notably, leaning into anxiety during ERP tasks was a key predictor of symptom improvement, offering new insights into refining OCD treatment strategies and enhancing clinical outcomes.

1.
Fawcett
EJ
,
Power
H
,
Fawcett
JM
.
Women are at greater risk of OCD than men: a meta-analytic review of OCD prevalence worldwide
.
J Clin Psychiatry
.
2020
;
81
(
4
):
19r13085
.
2.
Kessler
RC
,
Petukhova
M
,
Sampson
NA
,
Zaslavsky
AM
,
Wittchen
H-U
.
Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States
.
Int J Methods Psychiatr Res
.
2012
;
21
(
3
):
169
84
.
3.
Ruscio
AM
,
Stein
DJ
,
Chiu
WT
,
Kessler
RC
.
The epidemiology of obsessive-compulsive disorder in the national comorbidity survey replication
.
Mol Psychiatry
.
2010
;
15
(
1
):
53
63
.
4.
Remmerswaal
KCP
,
Batelaan
NM
,
Hoogendoorn
AW
,
van der Wee
NJA
,
van Oppen
P
,
van Balkom
AJLM
.
Four-year course of quality of life and obsessive–compulsive disorder
.
Soc Psychiatry Psychiatr Epidemiol
.
2020
;
55
(
8
):
989
1000
.
5.
Hauschildt
M
,
Jelinek
L
,
Randjbar
S
,
Hottenrott
B
,
Moritz
S
.
Generic and illness-specific quality of life in obsessive-compulsive disorder
.
Behav Cogn Psychother
.
2010
;
38
(
4
):
417
36
.
6.
American Psychiatric Association
.
Diagnostic and statistical manual of mental disorders
. 5th ed.
American Psychiatric Publishing, Inc.
;
2013
.
7.
Foa
EB
.
Cognitive behavioral therapy of obsessive-compulsive disorder
.
Dialogues Clin Neurosci
.
2010
;
12
(
2
):
199
207
.
8.
Öst
L-G
,
Enebrink
P
,
Finnes
A
,
Ghaderi
A
,
Havnen
A
,
Kvale
G
, et al
.
Cognitive behavior therapy for obsessive-compulsive disorder in routine clinical care: a systematic review and meta-analysis
.
Behav Res Ther
.
2022
;
159
:
104170
.
9.
National Instituate for Health and Care Excellence (NICE)
.
Surveillance of obsessive-compulsive disorder and body dysmorphic disorder: treatment (NICE guideline CG31)
. Surveillance report-and-conditions;
2019
. Available from: www.nice.org.uk
10.
Moritz
S
,
Külz
AK
,
Voderholzer
U
,
Hillebrand
T
,
McKay
D
,
Jelinek
L
.
“Phobie à deux” and other reasons why clinicians do not apply exposure with response prevention in patients with obsessive-compulsive disorder
.
Cogn Behav Ther
.
2019
;
48
(
2
):
162
76
.
11.
Hansen
B
,
Kvale
G
,
Hagen
K
,
Havnen
A
,
Öst
L-G
.
The Bergen 4-day treatment for OCD: four years follow-up of concentrated ERP in a clinical mental health setting
.
Cogn Behav Ther
.
2019
;
48
(
2
):
89
105
.
12.
Kvale
G
,
Hansen
B
,
Björgvinsson
T
,
Børtveit
T
,
Hagen
K
,
Haseth
S
, et al
.
Successfully treating 90 patients with obsessive compulsive disorder in eight days: the Bergen 4-day treatment
.
BMC Psychiatry
.
2018
;
18
(
1
):
323
9
.
13.
Launes
G
,
Hagen
K
,
Öst
LG
,
Solem
S
,
Hansen
B
,
Kvale
G
.
The Bergen 4-Day Treatment (B4DT) for obsessive-compulsive disorder: outcomes for patients treated after initial waiting list or self-help intervention
.
Front Psychol
.
2020
;
11
:
519002
.
14.
Jelinek
L
,
Serve
A
,
Pampuch
S
,
Scheunemann
J
,
Schultz
J
,
Miegel
F
, et al
.
Exploring the peaks and potholes: understanding positive and negative effects of concentrated exposure treatment for obsessive-compulsive disorder
.
J Obsessive Compuls Relat Disord
.
2024
;
43
:
100913
.
15.
Tjelle
K
,
Opstad
HB
,
Solem
S
,
Launes
G
,
Hansen
B
,
Kvale
G
, et al
.
Treatment adherence as predictor of outcome in concentrated exposure treatment for obsessive-compulsive disorder
.
Front Psychiatry
.
2021
;
12
:
667167
.
16.
Tjelle
K
,
Opstad
HB
,
Solem
S
,
Kvale
G
,
Wheaton
MG
,
Björgvinsson
T
, et al
.
Patient adherence as a predictor of acute and long-term outcomes in concentrated exposure treatment for difficult-to-treat obsessive-compulsive disorder
.
BMC Psychiatry
.
2024
;
24
(
1
):
327
8
.
17.
Dowling
N
,
Thomas
N
,
Blair-West
S
,
Bousman
C
,
Yap
K
,
Smith
DJ
, et al
.
Intensive residential treatment for obsessive-compulsive disorder: outcomes and predictors of patient adherence to cognitive-behavioural therapy
.
J Obsessive Compuls Relat Disord
.
2016
;
9
:
82
9
.
18.
Martin
DJ
,
Garske
JP
,
Davis
MK
.
Relation of the therapeutic alliance with outcome and other variables: a meta-analytic review
.
J Consult Clin Psychol
.
2000
;
68
(
3
):
438
50
.
19.
Saunders
SM
.
Clients’ assessment of the affective environment of the psychotherapy session: relationship to session quality and treatment effectiveness
.
J Clin Psychol
.
1999
;
55
(
5
):
597
605
.
20.
Pinto
A
,
Pinto
AM
,
Neziroglu
F
,
Yaryura-Tobias
JA
.
Motivation to change as a predictor of treatment response in obsessive compulsive disorder
.
Ann Clin Psychiatry
.
2007
;
19
(
2
):
83
7
.
21.
Steketee
G
,
Siev
J
,
Fama
JM
,
Keshaviah
A
,
Chosak
A
,
Wilhelm
S
.
Predictors of treatment outcome in modular cognitive therapy for obsessive-compulsive disorder
.
Depress Anxiety
.
2011
;
28
(
4
):
333
41
.
22.
Xu
J
,
Falkenstein
MJ
,
Kuckertz
JM
.
Feeling more confident to encounter negative emotions: the mediating role of distress tolerance on the relationship between self-efficacy and outcomes of exposure and response prevention for OCD
.
J Affect Disord
.
2024
;
353
:
19
26
.
23.
Mondloch
MV
,
Cole
DC
,
Frank
JW
.
Does how you do depend on how you think you’ll do? A systematic review of the evidence for a relation between patients’ recovery expectations and health outcomes
.
Can Med Assocciation J
.
2001
;
165
(
2
):
174
9
.
24.
Burlingame
GM
,
McClendon
DT
,
Yang
C
.
Cohesion in group therapy: a meta-analysis
.
Psychotherapy
.
2018
;
55
(
4
):
384
98
.
25.
Sheehan
DV
,
Lecrubier
Y
,
Harnett Sheehan
K
,
Amorim
P
,
Janavs
J
,
Weiller
E
, et al
.
The Mini International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview
.
J Clin Psychiatrylinical Psychiatry
.
1998
;
59
(
Suppl 2
):
22
33
.
26.
Goodman
WK
,
Price
LH
,
Rasmussen
SA
,
Mazure
C
,
Fleischmann
RL
,
Hill
CL
, et al
.
The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability
.
Arch Gen Psychiatry
.
1989
;
46
(
11
):
1006
11
.
27.
Mataix-Cols
D
,
Fernández de la Cruz
L
,
Nordsletten
AE
,
Lenhard
F
,
Isomura
K
,
Simpson
HB
.
Towards an international expert consensus for defining treatment response, remission, recovery and relapse in obsessive-compulsive disorder
.
World Psychiatry
.
2016
;
15
(
1
):
80
1
.
28.
Jacobsen
D
,
Kloss
M
,
Fricke
S
,
Hand
I
,
Moritz
S
.
Reliabilität der deutschen Version der Yale-Brown Obsessive Compulsive Scale
.
Verhaltenstherapie
.
2003
;
13
(
2
):
111
3
.
29.
Miegel
F
,
Rubel
J
,
Ching
THW
,
Yassari
A-H
,
Bohnsack
F
,
Duwe
M
, et al
.
How to assess and analyse sessionspecific effects and predictors: an example with the Metacognitive Training for Obsessive‐Compulsive Disorder intervention
.
Clin Psychol Psychother
.
2023
;
30
(
5
):
1158
69
.
30.
Simpson
HB
,
Maher
M
,
Page
JR
,
Gibbons
CJ
,
Franklin
ME
,
Foa
EB
.
Development of a patient adherence scale for exposure and response prevention therapy
.
Behav Ther
.
2010
;
41
(
1
):
30
7
.
31.
Cohen
J
.
Statistical power analysis for the behavioral sciences
. 2nd ed;
1988
.
32.
Friedman
J
,
Hastie
T
,
Tibshirani
R
.
Regularization paths for generalized linear models via coordinate descent
.
J Stat Softw
.
2010
;
33
(
1
):
1
22
.
33.
Stekhoven
DJ
.
Using the missForest package
. In:
missForest nonparametric missing value imput using random for R packag version 12
;
2012
. p.
1
11
.
34.
Reuter
B
,
Miano
A
,
Wassermann
J
,
Elsner
B
.
Why does exposure-based therapy fail in some individuals with obsessive-compulsive disorder
.
Expert Rev Neurother
.
2024
;
24
(
8
):
723
6
.
35.
Foa
EB
,
Kozak
MJ
.
Emotional processing of fear. Exposure to corrective information
.
Psychol Bull
.
1986
;
99
(
1
):
20
35
.
36.
Craske
MG
,
Kircanski
K
,
Zelikowsky
M
,
Mystkowski
J
,
Chowdhury
N
,
Baker
A
.
Optimizing inhibitory learning during exposure therapy
.
Behav Res Ther
.
2008
;
46
(
1
):
5
27
.
37.
Pittig
A
,
Heinig
I
,
Goerigk
S
,
Richter
J
,
Hollandt
M
,
Lueken
U
, et al
.
Change of threat expectancy as mechanism of exposure-based psychotherapy for anxiety disorders: evidence from 8,484 exposure exercises of 605 patients
.
Clin Psychol Sci
.
2023
;
11
(
2
):
199
217
.
38.
Ong
CW
,
Sheehan
KG
,
Xu
J
,
Falkenstein
MJ
,
Kuckertz
JM
.
A network analysis of mechanisms of change during exposures over the course of intensive OCD treatment
.
J Affect Disord
.
2024
;
354
:
385
96
.
39.
van de Mortel
TF
.
Faking it: social desirability response bias in selfreport research
.
Aust J Adv Nurs
.
2008
;
25
(
4
):
40
8
.
You do not currently have access to this content.